Global $6.4 Billion Influenza Market 2015-2017 & 2021

Dublin, July 20, 2017 -- The "The Global Influenza Market" report has been added to Research and Markets' offering.

This report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. and European data.

The report identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses.

Additionally, the study covers some of the most significant issues, trends and market factors.

Report Includes

- An overview of the global market for influenza vaccines, therapeutics, and diagnostics.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers, with a special emphasis on U.S. and European markets.
- Discussion of efforts by government agencies and disease prevention organizations to support and fund research and development programs, and pandemic prevention.
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.

Key Topics Covered:

1: Introduction

- Study Goals And Objectives
- Reasons For Doing The Study
- Scope Of Report
- Methodology And Information Sources

2: Summary

- The Influenza Market: Major Markets Summary

3: Industry Overview

- Overview
- History Of The Market
- The World Health Organization (Who) And The Centers For Disease Control And Prevention (Cdc): Influenza Response
- U.S. Viral Surveillance
- Vaccine Recommendations
- Population Demographics And Influenza Incidence/Mortality

4: Issues Affecting The Market

- H1N1 Outbreak 2009 (Swine Flu)
- Avian Flu
- International Influenza Vaccine Stockpile Orders
- Antiviral Resistance
- Recreated Viruses
- Immaterialized Market Risk
- Media Coverage And Vaccinations
- Epidemic/Pandemic Threat
- Pandemic Preparedness Plans

5: Patent Analysis

- Overview
- Influenza Patents By Patent Number

6: Influenza Vaccines

- Overview
- Current Vaccines
- Seasonal 2016-2017 Vaccine Approvals By Fda
- Pandemic Influenza Vaccines
- Vaccine Developments
- Global Competitor Analysis

7: Influenza Therapies

- Overview
- Current Therapies
- Generic Availability
- Influenza Treatment Developments
- Competitor Analysis

8: Influenza Diagnostics

- Overview
- Market Analysis
- Competitor Analysis

9: Influenza Market Summary

- Overview Of Influenza Market Trends
- Total Market Analysis

10: Company Profiles

- Significant Company Acquisitions
- Alere Inc.
- Astrazeneca/Medimmune
- Becton Dickinson And Company
- Cepheid
- Daiichi Sankyo
- Glaxosmithkline Plc
- Hologic Inc.
- Mitsubishi Tanabe Pharma Corp.
- Mylan N.V.
- Orasure Technologies
- Protein Sciences Corporation
- Qiagen N.V.
- Quidel Corp.
- Roche Ltd.
- Sanofi/Sanofi Pasteur
- Sekisui Diagnostics Llc
- Seqirus CSL Limited

11: Appendices

For more information about this report visit https://www.researchandmarkets.com/research/s936kj/the_global

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Infectious Diseases Drugs